Pain control with transverse abdominal muscle blocks

Comparison of control of pain in transverse abdominal muscle blocks method with injections of local analgesia effect at the incision site after unilateral inguinal hernia surgery

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201506226186N11

Enrollment

Registered

2015-09-08

Start date

2015-09-25

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoral hernia (unilateral) NOS. Unilateral or unspecified femoral hernia, without obstruction or gangrene

Interventions

Intervention 1: Tgroup: Transverse abdominis plane (TAP) block with ultrasound using 20 ml Bupivacaine 0.25% and adrenaline 1: 200,000 in the surgical area. Intervention 2: I group: infiltration of 2

Treatment - Drugs

Tgroup: Transverse abdominis plane (TAP) block with ultrasound using 20 ml Bupivacaine 0.25% and adrenaline 1: 200,000 in the surgical area

I group: infiltration of 20 ml 0.25% Marcain in 1:200000 Adrenalin in the surgery site

Eligibility

Sex/Gender

All

Age

16 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Candidates for unilateral inguinal hernia surgery; ASA class I,II Exclusion criteria: Unexpected bleeding;Cardiovascular events; Severe hypertension

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: 1, 2, 4, 6, 12, 18 up to 24 hours after surgery. Method of measurement: Visual Analogue Scale (VAS)\Questionnaire.;Nausea. Timepoint: 1, 2, 4, 6, 12, 18 up to 24 hours after surgery. Method of measurement: Yes/No-Questionnaire.;Drowsiness. Timepoint: 1, 2, 4, 6, 12, 18 up to 24 hours after surgery. Method of measurement: Yes/No-Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBahram Naderi Nabi

Guilan University of Medical Sciences

arcguilan1392@gmail.com+98 13 3336 8534

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026